Medtronic To Pay J&J $270M Over Stent Patent Fees
By Erin Marie Daly ( May 11, 2009, 12:00 AM EDT) -- Medtronic Inc. has agreed to fork over $270 million in a bid to bury the hatchet with Johnson & Johnson in a long-running dispute over royalties concerning three stent patents used in heart surgeries....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.